Agios Pharmaceuticals Inc
Latest Agios Pharmaceuticals Inc News and Updates
How Jazz Pharmaceuticals Aims to Boost Vyxeos Sales in 2017
In early 2017, Jazz Pharmaceuticals (JAZZ) expanded its sales force team from 35 to 55 and expanded its field reimbursement teams to support the commercial launch of Vyxeos in the US.
What Jazz Pharmaceuticals Expects for Vyxeos
If Vyxeos manages to penetrate a sizeable portion of the target market, it may have a favorable impact on Jazz Pharmaceuticals stock.